Hyperaldosteronism screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hyperaldosteronism}} | {{Hyperaldosteronism}} | ||
{{CMG}}; '''Assistant Editor-in-Chief:''' [[User:Soumya Sachdeva|Soumya Sachdeva]] | |||
{{ | {{PleaseHelp}} | ||
==Overview== | ==Overview== | ||
Screening for hyperaldosteronism is done by measuring the aldosterone-renin ratio(ARR) on current blood pressure medication (stop spironolactone for 4 weeks) and with hypokalemia corrected (ARR screen positive if ARR>750 pmol/l:ng/ml/h and aldosterone>450 pmol/l)<ref>Harrison's Principles of Internal Medicine</ref> | Screening for hyperaldosteronism is done by measuring the aldosterone-renin ratio(ARR) on current blood pressure medication (stop spironolactone for 4 weeks) and with hypokalemia corrected (ARR screen positive if ARR>750 pmol/l:ng/ml/h and aldosterone>450 pmol/l)<ref>Harrison's Principles of Internal Medicine</ref> | ||
==Screening== | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
| Line 15: | Line 17: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
{{WS}} | |||
{{WH}} | |||
Revision as of 00:43, 24 July 2016
|
Hyperaldosteronism Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor-in-Chief: Soumya Sachdeva
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Screening for hyperaldosteronism is done by measuring the aldosterone-renin ratio(ARR) on current blood pressure medication (stop spironolactone for 4 weeks) and with hypokalemia corrected (ARR screen positive if ARR>750 pmol/l:ng/ml/h and aldosterone>450 pmol/l)[1]
Screening
References
- ↑ Harrison's Principles of Internal Medicine